Advanced MRI Measures of Repair in Alemtuzumab Treated Patients
Status:
Completed
Trial end date:
2018-09-28
Target enrollment:
Participant gender:
Summary
There are two parts to this investigator sponsored trial (IST):
1. To perform advanced serial MRI studies on patients initiating alemtuzumab therapy.
2. To provide serum samples for the University of Southern California (USC) ICAM125
lymphocyte recovery study.